马来酸罗格列酮(文迪亚)致白细胞下降一例报道

下载PDF

导出

摘要马来酸罗格列酮（文迪亚）属于噻唑烷二酮类TZD降糖药。可增强胰岛素在外周组织如肝脏，肌肉，脂肪的敏感性，减少胰岛素抵抗，为胰岛素增敏剂。药物进入靶细胞之后与核受体结合，

作者温伟波王家玲

机构地区云南省中医医院云南中医学院

出处《实用糖尿病杂志》 2011年第1期55-55,共1页 Journal of Practical Diabetology

关键词马来酸罗格列酮文迪亚白细胞下降胰岛素抵抗噻唑烷二酮类胰岛素增敏剂外周组织受体结合

参考文献1

1Daniel H,Joseph F,Richard A.et al.Thickening of the carotid wall a marker for atherosclerosis in the elderly[J] ? Stroke,1996;27:224 -231.
2Noriko S,Yoshihiro O,Takeshi U,et al.Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect[J].Diabetes Care,2003;26:2493-2499.
3Wagenknecht LE,D'Agostino R,Sarage PJ,et al.Duration of diabetes and carotid wall thicknessthe insulin resistance atherosclerosis study (IRAS) duration of diabetes and carotid wall thickness[J].Stroke,1997;28:999 -1005.
4Wagenknecht LE,Zaccaro D,Espeland MA,et al.Diabetes and progression of carotid atherosclerosis the insulin resistance atherosclerosis study.Arterioscler[J].Thromb Vasc Biol,2003;3:1035-1041.
5Du XL,Edelstein D,Dimmeler S,et al.Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site[J].J Clin Invest,2001 ;108:1341-1348.
6Teno S,Uto Y,Nagashima H,et al.Association of postprandial hypertri-glyceridemia and carotid intima-media thickness in patients with type2 diabetes[J].Diabetes Care,2000;23:1401-1406.

实用糖尿病杂志

2011年第1期

内容加载中请稍等...